Unbound MEDLINE

Diurnal variations in the parameters of pulmonary function and respiratory muscle strength in patients with COPD.

Abstract

OBJECTIVE
To evaluate the magnitude of diurnal changes in the parameters of pulmonary function and respiratory muscle strength/endurance in a sample of patients with COPD.
METHODS
A group of 7 patients underwent spirometry, together with determination of MIP and MEP, at two distinct times (between 8:00 and 8:30 a.m. and between 4:30 and 5:00 p.m.) on a single day. Between assessments, the patients remained at rest in the laboratory.
RESULTS
In accordance with the Global Initiative for Chronic Obstructive Pulmonary Disease staging system, COPD was classified as moderate, severe, and very severe in 1, 3, and 3 of the patients, respectively. From the first to the second assessment, there were significant decreases in FVC, FEV1, and MEP (of 13%, 15%, and 10%, respectively), as well as (less than significant) decreases in PEF, MIP, and maximal voluntary ventilation (of 9%, 3%, and 11%, respectively).
CONCLUSIONS
In this sample of COPD patients, there were diurnal variations in the parameters of pulmonary function and respiratory muscle strength. The values of FEV1, FVC, and MEP were significantly lower in the afternoon than in the morning.

Links

  • Publisher Full Text
  • Authors

    Fregonezi G, Resqueti VR, Cury JL, Paulin E, Brunetto AF

    Institution

    Laboratory of Respiratory Physical Therapy, Department of Physical Therapy, Regional University Hospital of Northern Paraná, State University at Londrina, Londrina, Brazil. fregonezi@ufrnet.br

    Source

    Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia 38:2 2012 Apr pg 257-63

    MeSH

    Aged
    Circadian Rhythm
    Female
    Humans
    Male
    Middle Aged
    Muscle Strength
    Pulmonary Disease, Chronic Obstructive
    Respiratory Function Tests
    Respiratory Muscles
    Severity of Illness Index
    Spirometry

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng por

    PubMed ID

    22576435